ID
39893
Description
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00928252
Link
https://clinicaltrials.gov/show/NCT00928252
Keywords
Versions (1)
- 3/1/20 3/1/20 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
March 1, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hormone Refractory Prostate Cancer NCT00928252
Eligibility Hormone Refractory Prostate Cancer NCT00928252
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Cancer Other | Exception Basal cell carcinoma | Exception Superficial transitional cell carcinoma of bladder
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0007117
- UMLS CUI [3,1]
- C1705847
- UMLS CUI [3,2]
- C0279680
- UMLS CUI [3,3]
- C0205124
Description
Medical condition Serious Impairing Imaging
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3843040
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [1,3]
- C0221099
- UMLS CUI [1,4]
- C0011923
Description
High weight
Data type
boolean
Alias
- UMLS CUI [1]
- C0948775
Description
Life Expectancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0023671
Description
Study Subject Participation Status | Radiopharmaceuticals Cumulative Dose per year Estimated
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2,1]
- C0182638
- UMLS CUI [2,2]
- C2986497
- UMLS CUI [2,3]
- C0439508
- UMLS CUI [2,4]
- C0750572
Description
Concurrent therapy allowed | Prior Chemotherapy allowed | Hormone Therapy | Prior surgery | Diphosphonates | Biological agents allowed
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009429
- UMLS CUI [1,2]
- C0683607
- UMLS CUI [2,1]
- C1514457
- UMLS CUI [2,2]
- C0683607
- UMLS CUI [3]
- C0279025
- UMLS CUI [4]
- C0455610
- UMLS CUI [5]
- C0012544
- UMLS CUI [6,1]
- C0005515
- UMLS CUI [6,2]
- C0683607
Similar models
Eligibility Hormone Refractory Prostate Cancer NCT00928252
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0600139 (UMLS CUI [3])
C0178415 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0201544 (UMLS CUI [3])
C0231290 (UMLS CUI [2,1])
C0002842 (UMLS CUI [2,2])
C2349954 (UMLS CUI [2,3])
C1328504 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C1705938 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3,1])
C2830183 (UMLS CUI [3,2])
C1705938 (UMLS CUI [3,3])
C0392920 (UMLS CUI [4,1])
C0026259 (UMLS CUI [4,2])
C1705938 (UMLS CUI [4,3])
C0754011 (UMLS CUI [5])
C0303282 (UMLS CUI [6])
C3496793 (UMLS CUI [7])
C1706668 (UMLS CUI [8])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0279680 (UMLS CUI [3,2])
C0205124 (UMLS CUI [3,3])
C0205404 (UMLS CUI [1,2])
C0221099 (UMLS CUI [1,3])
C0011923 (UMLS CUI [1,4])
C0182638 (UMLS CUI [2,1])
C2986497 (UMLS CUI [2,2])
C0439508 (UMLS CUI [2,3])
C0750572 (UMLS CUI [2,4])
C0683607 (UMLS CUI [1,2])
C1514457 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0279025 (UMLS CUI [3])
C0455610 (UMLS CUI [4])
C0012544 (UMLS CUI [5])
C0005515 (UMLS CUI [6,1])
C0683607 (UMLS CUI [6,2])